BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 14576419)

  • 1. Choices--and uncertainties--for women with BRCA mutations.
    Couzin J
    Science; 2003 Oct; 302(5645):592. PubMed ID: 14576419
    [No Abstract]   [Full Text] [Related]  

  • 2. Perspectives in the clinical management of BRCA mutations carriers.
    Savarese A; Cognetti F
    J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):31-5. PubMed ID: 12585651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving surveillance and quality of life of BRCA mutation carriers.
    Loman N; Borg A
    J Clin Oncol; 2010 Aug; 28(22):e376-7. PubMed ID: 20458044
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk reduction works for BRCA mutation carriers--with heavy costs.
    Vanchieri C
    J Natl Cancer Inst; 2005 Jul; 97(14):1032-3. PubMed ID: 16030299
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention and management of hereditary breast cancer.
    Narod SA; Offit K
    J Clin Oncol; 2005 Mar; 23(8):1656-63. PubMed ID: 15755973
    [No Abstract]   [Full Text] [Related]  

  • 6. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
    Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
    Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing breast, ovarian cancer in BRCA carriers: rational of prophylactic surgery and promises of surveillance.
    Agnantis NJ; Paraskevaidis E; Roukos D
    Ann Surg Oncol; 2004 Dec; 11(12):1030-4. PubMed ID: 15545500
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic approaches for women predisposed to breast cancer.
    Nathanson KL; Domchek SM
    Annu Rev Med; 2011; 62():295-306. PubMed ID: 21034216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproductive issues for women with BRCA mutations.
    Friedman LC; Kramer RM
    J Natl Cancer Inst Monogr; 2005; (34):83-6. PubMed ID: 15784831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome.
    Roukos DH; Briasoulis E
    Nat Clin Pract Oncol; 2007 Oct; 4(10):578-90. PubMed ID: 17898808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
    Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
    Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: "Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations".
    Olivier RI; van Beurden M
    Gynecol Oncol; 2005 Nov; 99(2):520-1. PubMed ID: 16188301
    [No Abstract]   [Full Text] [Related]  

  • 14. BRCA1 and BRCA2 variants of uncertain significance. Part two: medical management.
    Miller-Samuel S; Rosenberg A; Berger A; Gomella L; Loren D; Morris GJ
    Semin Oncol; 2011 Oct; 38(5):605-11. PubMed ID: 21943665
    [No Abstract]   [Full Text] [Related]  

  • 15. Hereditary ovarian cancer--assessing risk and prevention strategies.
    Pavelka JC; Li AJ; Karlan BY
    Obstet Gynecol Clin North Am; 2007 Dec; 34(4):651-65, vii-viii. PubMed ID: 18061862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of breast cancer in carriers of BRCA gene mutations.
    Birkmeyer JD; Welch HG
    N Engl J Med; 1997 Sep; 337(11):787-8; author reply 789. PubMed ID: 9289638
    [No Abstract]   [Full Text] [Related]  

  • 17. A survey of preventive measures among BRCA1 mutation carriers from Poland.
    Gronwald J; Byrski T; Huzarski T; Cybulski C; Stawicka M; Szwiec M; Debniak T; Tulman A; Sun P; Oszurek O; Lubinski J; Narod SA
    Clin Genet; 2007 Feb; 71(2):153-7. PubMed ID: 17250664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of the BRCA mutation carrier or high-risk patient.
    Bordeleau LJ; Lipa JE; Neligan PC
    Clin Plast Surg; 2007 Jan; 34(1):15-27; abstract v. PubMed ID: 17307068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical risk reduction: prophylactic salpingo-oophorectomy and prophylactic mastectomy.
    Dowdy SC; Stefanek M; Hartmann LC
    Am J Obstet Gynecol; 2004 Oct; 191(4):1113-23. PubMed ID: 15507929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling the next chapter: sexual development, body image, and sexual functioning in female BRCA carriers.
    Matloff ET; Barnett RE; Bober SL
    Cancer J; 2009; 15(1):15-8. PubMed ID: 19197168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.